Coumadin and Brovana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coumadin (warfarin sodium) and Brovana (arformoterol tartrate). Common drug interactions include cystitis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Coumadin and Brovana. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Coumadin?

Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 133,228 Coumadin users. Check the latest studies of Coumadin.

What is Brovana?

Brovana has active ingredients of arformoterol tartrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 3,656 Brovana users. Check the latest studies of Brovana.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 19, 2026

70 people who take Coumadin and Brovana together, and have interactions are studied.

Coumadin and Brovana drug interactions.

What are the common drug interactions of Coumadin and Brovana, by gender? *:

female:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Diarrhoea
  3. Dizziness
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. General physical health deterioration (weak health status)
  6. Herpes zoster
  7. International normalised ratio increased
  8. Kidney infection
  9. Oxygen saturation decreased
  10. Vasculitis (inflammation of a blood vessel or blood vessels)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Oedema (fluid collection in tissue)
  4. Pneumonia
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Rectal haemorrhage (bleeding from anus)
  7. Anticoagulation drug level above therapeutic
  8. Dizziness
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Muscular weakness (muscle weakness)

What are the common drug interactions of Coumadin and Brovana, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chest pain
  2. Dizziness
  3. Nausea (feeling of having an urge to vomit)
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Cystitis (inflammation of the wall of the bladder)
  6. General physical health deterioration (weak health status)
  7. Herpes zoster
  8. Kidney infection
  9. Pneumonia
  10. Vasculitis (inflammation of a blood vessel or blood vessels)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Rectal haemorrhage (bleeding from anus)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Abdominal pain
  8. Anticoagulation drug level above therapeutic
  9. Asthenia (weakness)
  10. Death

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 15.71%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 10.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 10.00%
  4. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 5.71%
  5. Dyspnea (difficult or laboured breathing): 4 people, 5.71%
  6. Asthma: 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Coumadin and Brovana?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coumadin and Brovana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coumadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brovana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coumadin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brovana and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium and arformoterol tartrate (the active ingredients of Coumadin and Brovana, respectively), and Coumadin and Brovana (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: